NCT03215810 2023-07-24Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed20 enrolled 10 charts